Navigation Links
Cardium Launches New AWARE Clinical Study Website
Date:6/11/2008

with diabetes.

About Generx

Generx(TM) (alferminogene tadenovec, Ad5FGF-4) is the lead product candidate in a new class of cardiovascular biologics that is being developed to leverage the body's natural healing processes in response to repeated ischemic stress (insufficient blood flow and myocardial oxygen supply due to coronary heart disease). The natural biologic response to repeated transient ischemia is angiogenesis, the growth of new collateral blood vessels, which is orchestrated by a complex and incompletely understood cascade involving many growth factors. These newly-formed vessels can effectively augment blood flow and oxygen delivery to parts of the patient's heart downstream from a blockage in a coronary artery. In many patients however, including those with recurrent angina, coronary collateral vessel formation is insufficient to meet the heart's needs during stress. Currently available anti-anginal drugs, which may provide symptomatic relief, are generally designed to alter the oxygen demand of the heart muscle or dilate vessels to temporarily relieve angina. Generx is designed to be a disease-modifying angiogenic therapeutic to promote the heart's natural response to ischemia through the growth of new blood vessels to increase blood flow within the heart muscle.

Cardium's therapeutic approach to the treatment of myocardial ischemia associated with coronary heart disease has been the focus of the most widely-conducted clinical studies for Angiogenic Gene Therapy (AGENT-1 through AGENT-4), which involved 663 patients at more than 100 U.S., European and other international medical centers. Generx represents the first and only DNA-based cardiovascular therapeutic to be advanced to Phase 3, and the Company believes it to be the only current Phase 3 product candidate for the potential treatment of patients with stable angina, a chronic medical condition affecting millions of patients in the U.S. and worldwide.

About Cardium

<
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
11. Novozymes Launches Enzyme to Reduce Acrylamide in Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) today announced ... master services agreement with a multi-billion dollar ... serve patients in approximately 100 countries. With ... provider for translation of the company,s online ... resources, legal, and corporate communications information. Lionbridge ...
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), ... royalty revenue from sales of Thalomid® during the ... $3.3 million. In addition, the Company anticipates ... for fiscal 2009. The difference in estimated ... be reflected in the fourth quarter financial results. ...
(Date:12/11/2009)... SAN DIEGO, Dec. 11 Ambit Biosciences Corporation ... of Texas M. D. Anderson Cancer Center of the ... 220 Monotherapy E fficacy) Phase 2 ... myeloid leukemia (AML). AC220 is a novel, orally ... specifically designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... Hatboro, PA December 11, 2009 -- Esco announces the opening of ... will serve as a technical service, training and logistics center to ... area of New Product Introductions (NPI) for temperature-controlled laboratory equipment. ... ... announces the opening of a NEW 2nd North American facility in ...
Breaking Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3EntreMed Reports Receipt of Third Quarter Royalty Payment 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... Wis. - Teresa Esser sees incredible opportunity ... the new director of the Milwaukee-based Silicon Pastures ... of that opportunity realized. , ,While others are talking ... Wisconsin, particularly in the tech sector, Esser sees plenty ...
... I am a northern Wisconsin boy - Marinette County. My hometown, Marinette, ... there in the 1950s and 1960s. Why? , ,It can be ... John Roach once told me that an indicator of the strength of ... harsh truth is that only one of the friends I grew up ...
... West Central Wisconsin Workforce Resource is inviting representatives from ... Conference titled "Positioning for Economic Growth." , ,The conference is ... to 5 p.m. and Sept. 21 from 8 a.m. to ... Student Center . , ,Although some speakers have not ...
Other Biology Technology:New Silicon Pastures director envisions more home cooking for Wisconsin angels 2New Silicon Pastures director envisions more home cooking for Wisconsin angels 3New Silicon Pastures director envisions more home cooking for Wisconsin angels 4New Silicon Pastures director envisions more home cooking for Wisconsin angels 5New Silicon Pastures director envisions more home cooking for Wisconsin angels 6Madison is flourishing while Marinette is dying 2Madison is flourishing while Marinette is dying 3Conference to address small town development 2
(Date:12/14/2009)... 14, 2009) -- Researchers at Rice University and Baylor ... that can be tracked in real time with MRI ... with a fluorescent dye and kills them with heat. ... from a growing field called "theranostics" that develops technologies ... a single procedure. , The research is available online ...
(Date:12/14/2009)... transmitted by sneezing, touching, or for Tasmanian devils ... that may have driven the dinosaurs to extinction through ... a member of f1000 Biology, highlights the ,paleobiological detective ... One. This led them to deduce that a protozoan ... seen in many tyrannosaurid fossils. , The parasite,s modern-day ...
(Date:12/14/2009)... the holidays with big Uncle Frank or bossy Aunt ... with another family, spare a thought for the humble ... University and the University of New South Wales has ... groups, members make strategic decisions about their living situation. ... of Biology Letters . , The helper class ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 1Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 2Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 3Flexible solar strips light up campus bus shelter 8814 1Flexible solar strips light up campus bus shelter 8814 2Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 1Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 2Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 48772 3
... have discovered how a prevalent fungal pathogen that causes ... the effects of antifungal drugs by duplicating a section ... a type of yeast present in 80 percent of ... can cause mild oral and vaginal infections (candiasis or ...
... Harbor Branch scientists, along with colleagues from the University ... submersible to explore for the first time newly discovered ... were discovered in 2,000 to 2,900 feet of water ... advanced sonar techniques. A primary goal of the ...
... that molecule-of-all-trades, is famous for its roles in shaping ... universal solvent. , Now, researchers at the University ... Czech Republic have uncovered two previously unknown roles for ... roles in living cells and show promising medical applications. ...
Other Biology News:U of M researchers discover genetic key to treating deadly fungal infections 2Drug discovery team to explore newly discovered deep-sea reefs 2Drug discovery team to explore newly discovered deep-sea reefs 3Rehydrate -- your RNA needs it 2Rehydrate -- your RNA needs it 3
Human VEGF R Phycoerythrin Sampler (Cl 89106, 49560, 54733)...
RABBIT ANTI NEOPTERIN...
MOUSE ANTI SIMIAN VIRUS 5:FITC Immunogen: Simian virus 5...
... Dog Serum-Mixed Breed • Dog serum is ... over one year of age Available Anticoagulants: ... Heparin (Na) N-06: K2EDTA N-08: ... N-03: Alsevers N-05: ACD ...
Biology Products: